Cargando…

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort

The prevalence of transmitted drug resistance (TDR) in antiretroviral therapy (ART)-naïve individuals remains stable in most developed countries despite a decrease in the prevalence of acquired drug resistance. This suggests that persistence and further transmission of HIV-1 that encodes transmitted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machnowska, Patrycja, Meixenberger, Karolin, Schmidt, Daniel, Jessen, Heiko, Hillenbrand, Heribert, Gunsenheimer-Bartmeyer, Barbara, Hamouda, Osamah, Kücherer, Claudia, Bannert, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334938/ https://www.ncbi.nlm.nih.gov/pubmed/30650082 http://dx.doi.org/10.1371/journal.pone.0209605

Ejemplares similares

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o
por: Wang, Bo, et al.
Publicado: (2019)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses
por: Hauser, Andrea, et al.
Publicado: (2018)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT
por: Machnowska, Patrycja, et al.
Publicado: (2017)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

No significant HTLV seroprevalence in German people who inject drugs
por: Hohn, Oliver, et al.
Publicado: (2017)

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
por: Wenz, Benjamin, et al.
Publicado: (2016)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019)

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany
por: Pantke, Annemarie, et al.
Publicado: (2022)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones
por: Hanke, Kirsten, et al.
Publicado: (2020)

A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
por: Zimmermann, Ruth, et al.
Publicado: (2014)

580. Key Factors for Treatment Changes Within 1 Year After Starting ART in the German ClinSurv Cohort: Between 2005 and 2014
por: Stecher, Melanie, et al.
Publicado: (2018)

Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls
por: Santos-Hövener, Claudia, et al.
Publicado: (2014)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission
por: Hauser, Andrea, et al.
Publicado: (2015)

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005
por: Gilsdorf, Andreas, et al.
Publicado: (2010)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland
por: Smoleń-Dzirba, Joanna, et al.
Publicado: (2017)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
por: Huang, Xiaojie, et al.
Publicado: (2016)

Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection
por: Li, Yunqi, et al.
Publicado: (2023)

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011)

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
por: Campbell, Mary S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h1bkcnfduelc0vacqsv9f8g9k2